Immunoassay News and Research

RSS

USPSTF urges universal syphilis screening in pregnancy to prevent congenital infections

The US Preventive Services Task Force (USPSTF) reaffirms its recommendation for universal syphilis screening in pregnancy, citing strong evidence for early detection and prevention of congenital syphilis. Despite ongoing disparities and rising rates, early screening and treatment remain essential to improving outcomes for mothers and infants.

18 May 2025

Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits

Tecan Group today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc.

7 Apr 2025

Blood test for Alzheimer’s could replace costly and invasive spinal taps

Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing Alzheimer's disease.

20 Feb 2025

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit Reagents and Gyrolab HEK293 HCP Type CL Kit Reagents.

6 Feb 2025

Spear Bio secures FDA breakthrough device designation for its novel pTau 217 blood test, advancing scalable solutions for early Alzheimer's disease diagnosis

Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

From Spear Bio 15 Jan 2025

Ultra-processed foods linked to liver disease and insulin resistance in obese children

Ultra-processed food consumption in obese adolescents is linked to insulin resistance and liver disease, stressing the need for improved dietary interventions.

22 Oct 2024

New study links persistent SARS-CoV-2 proteins to long COVID symptoms

Brigham researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms.

9 Oct 2024

AB ANALITICA x SNIBE partnership – July 22, 2024

AB ANALITICA and SNIBE are proud to announce a distribution partnership in Italy for SNIBE Molecision R8 platform, and both companies will focus on the development and commercialization of next-generation molecular tests on this platform.

From AB ANALITICA 23 Sep 2024

Janus particles enable highly precise measurements in microfluidic devices

The importance of testing for diseases was thrust into the limelight during the COVID-19 pandemic. Many of us have undergone a PCR (Polymerase Chain Reaction) or ELISA (Enzyme-Linked Immunosorbent Assay) test within the past four years.

20 Sep 2024

Study reveals population-wide immune setpoint for SARS-CoV-2 antibodies

Researchers discovered that SARS-CoV-2 antibody levels in the Dominican Republic converge to a population-wide immune setpoint, regardless of individual vaccination or infection history.

10 Sep 2024

New portable biosensor could revolutionize heart failure screening at home

Heart failure is a leading cause of death worldwide and is especially fatal for people who don't have access to medical facilities. So, a team of researchers aims to bring heart failure screening from the lab to the home.

19 Aug 2024

Cervical mucus biomarkers could improve early detection of cervical cancer

Cervical cancer is a highly prevalent cancer, with approximately 500,000 new cases diagnosed each year.

5 Aug 2024

Spear Bio secures $45 million in oversubscribed Series A financing to accelerate product launch for protein research and disease diagnostics

WOBURN, Mass.–(BUSINESS WIRE)–Spear Bio Inc., a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment, announced the successful closing of its $45 million Series A financing.

From Spear Bio 31 Jul 2024

COVID-19 and metallic taste: Study connects immunoglobulin levels to sensory impairment

Researchers investigated whether COVID-19-related sensory deficiencies are associated with transcriptome changes in the foliate papillae area of the tongue.

9 Jul 2024

Radiometer and Etiometry announce commercial partnership to empower physicians by optimizing workflows and decision making in high acuity care settings

Radiometer, a leading medical device company specializing in acute care testing solutions, and Etiometry, a leader in clinical decision-support software for critical care, today announced a new commercial partnership to enhance clinical decision making and workflows in hospital settings.

From Radiometer Medical 1 Jul 2024

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

Despite efforts, tumor recurrence is diagnosed in 35–40% of patients with stage III squamous cell lung carcinoma (SCLC) during the first year after treatment.

25 Jun 2024

Unveiling the role of auto-antibodies in COVID-19 severity

Even though COVID-19 manifests as a mild and short-lived disease in most people, some suffer extremely severe symptoms; in the worst cases, these patients die due to complications such as respiratory failure or thromboembolism.

19 Jun 2024

Nanobody technology revolutionizes food allergy detection methods

Recent advancements show nanobodies from camelid antibodies excel in food allergen detection with superior stability, specificity, and cost-effectiveness. This innovative approach aims to improve accuracy and efficiency, crucial for preventing severe allergic reactions. The study highlights nanobodies' potential in reliable immunoassays, addressing rising food allergies and enhancing safety measures. Food allergies pose significant health risks, affecting millions worldwide, with the prevalence rising over the past decades.

18 Jun 2024

At-home antibody tests could drive higher COVID-19 booster rates, new research finds

The feasibility and benefits of lateral flow assay (LFA)-based antibody tests for detecting inadequate COVID-19 immunity.

17 Jun 2024

Heart attack diagnosis innovation - from an hour to eight minutes

In this Interview, News Med talks to Femke de Theije about heartfelt innovation for emergency care.

From Siemens Healthineers 6 Jun 2024